A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

July 28, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions
Postoperative Pain Management
Interventions
DRUG

HSK21542

Patients administrated with HSK21542

DRUG

Placebo

Patients administrated with placebo

DRUG

morphine

Patients administrated with morphine

Trial Locations (2)

Unknown

RECRUITING

Xuanwu Hospital Capital Medical University, Beijing

RECRUITING

Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY